Assenagon Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $262M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $56.8M | Sell |
|
|||||
|
2020
Q3 | $81.8M | Buy |
|
|||||
|
2020
Q2 | $42.4M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $11.1M | Sell |
|
|||||
|
2019
Q3 | $12.1M | Buy |
|
|||||
|
2019
Q2 | $2.23M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $10.2M | Sell |
|
|||||
|
2018
Q3 | $17M | Sell |
|
|||||
|
2018
Q2 | $38.9M | Buy |
|
|||||
|
2018
Q1 | $7.98M | Sell |
|
|||||
|
2017
Q4 | $60.1M | Sell |
|
|||||
|
2017
Q3 | $124M | Buy |
|
|||||
|
2017
Q2 | $2.33M | Buy |
|